Increased Rate of Bacterial Infection Hospitalizations With Substance Use Disorder
Rates of hospitalizations for serious bacterial infections among people with substance use disease are increasing, especially in younger populations.
Nosocomial Infections
Most Risk Factors for Prosthetic Joint Infection Treatment Nonresponse Hard to Modify
Eradication of prosthetic hip and knee joint infections is challenging, with failure rates >20% even in the setting of complete prosthesis removal.
Social Risk Factors Associated With Post-Colectomy Surgical Site Infections
Infection prevention programs targeting low-income groups undergoing colectomy may be important in reducing surgical site infections.
Antimicrobial Resistance Patterns Examined for Adult, Pediatric HAIs
Recent reports present updated summaries of common pathogens and antimicrobial resistance patterns among health care-associated infections.
Trends in Rates of Hospitalized Infections Among Adults With Diabetes vs Those Without
There is a need to improve infectious risk mitigation in adults with diabetes because they are hospitalized for infections between 2.6 and 15.7 times as often as adults without diabetes, depending on the type of infection.
Carbapenem Nonsusceptible GNB Linked to In-Hospital Mortality
Among individuals with acute myelogenous leukemia (AML), carbapenem-nonsusceptible gram-negative bacteremia (GNB) is associated with worse outcomes than carbapenem-susceptible GNB.
Closed ICU Model May Reduce Hospital-Acquired Infections
A closed ICU model is associated with a reduction in certain types of hospital-acquired infections.
Hospital-Treated Infections Linked to Risk for Adolescent Eating Disorders
Infections that require hospitalization and treatment with anti-infective agents in childhood are associated with an increased risk for eating disorders in adolescent girls.
Safety and Efficacy of Ceftolozane/Tazobactam for Nosocomial Pneumonia
The novel combination antibacterial agent ceftolozane/tazobactam had comparable clinical and microbiologic response rates to meropenem in treating gram-negative nosocomial pneumonia.
Ceftolozane/Tazobactam Noninferior to Meropenem for Nosocomial Pneumonia
A combination dose of ceftolozane/tazobactam is noninferior to meropenem for treating nosocomial pneumonia.
